Olmesartan/Amlodipine/Hydrochlorothiazide in Obese Participants With Hypertension: A TRINITY Subanalysis

The objective of this prespecified TRINITY study subgroup analysis was to assess the efficacy and safety of triple‐combination treatment with olmesartan medoxomil (OM) 40 mg, amlodipine besylate (AML) 10 mg, and hydrochlorothiazide (HCTZ) 25 mg vs the component dual‐combination treatments in obese (...

Descripción completa

Detalles Bibliográficos
Autores principales: Roth, Eli M., Oparil, Suzanne, Melino, Michael, Lee, James, Fernandez, Victor, Heyrman, Reinilde
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2013
Materias:
Original Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3908371/
https://www.ncbi.nlm.nih.gov/pubmed/23889722
http://dx.doi.org/10.1111/jch.12133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3908371/
https://www.ncbi.nlm.nih.gov/pubmed/23889722
http://dx.doi.org/10.1111/jch.12133

Ejemplares similares